National Clinical Guideline for the Diagnosis, Staging and Treatment of Prostate Cancer

The NCCP have now updated the radiology and diagnosis sections of the National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer.

The updated section ‘Diagnosis and Staging of patients with prostate cancer (2022)’ can be found below. Please note the updated section (2022) now supersedes the recommendations of the diagnostic section within the National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer (2015).

Guidelines

Diagnosis and Staging of patients with prostate cancer (2022)

For men with prostate cancer post definitive surgical or radiotherapy treatment, what is the optimum follow up protocol to monitor for a biochemical prostate cancer recurrence? (2023)

National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer (2015)

Consensus Statement 

Prostate Cancer Moderate Hypofractionation Interim Recommendations Consensus Group Statement June 2023

Policy

NCCP National Policy on the Prevention and Management of Infection Post Transrectal Ultrasound (TRUS Guided Prostate Biopsy) (2014)

Last updated: 30/04/2024